Paul Bolot

Paul Bolot is currently a Global Regulatory Strategist at Bayer, where they define and monitor global regulatory science related to anticancer drug development. Previously, they held various roles at Bayer, including a Global Regulatory Affairs Intern, where they focused on immuno-oncology drug assessment. They also served as a Senior Regulatory Specialist at PharmaLex, managing international regulatory activities for medicines and medical devices. Paul obtained a Doctor of Pharmacy from Université de Lorraine and a Master's degree in Regulatory Affairs from Paris-Sud University.